Status:

COMPLETED

Neuromodulation and Yoga for Mild Traumatic Brain Injury and Chronic Pain

Lead Sponsor:

VA Office of Research and Development

Conditions:

Mild Traumatic Brain Injury

Chronic Pain

Eligibility:

All Genders

22+ years

Phase:

NA

Brief Summary

The objectives of this VA SPiRE application are to develop a combined neuromodulation and yoga (iTBS+yoga) intervention for Veterans with mild traumatic brain injury (mTBI) and chronic pain, assess th...

Detailed Description

Over 340,000 people have incurred a mild traumatic brain injury (mTBI) as a result of the military conflicts in Iraq and Afghanistan. mTBI leads to a host of poor rehabilitation outcomes including imp...

Eligibility Criteria

Inclusion

  • 22+ years of age
  • Can read and speak English
  • Perceive themselves as able to participate in gentle physical movements and cleared by study physician to do so.
  • mTBI Criteria: Symptom Attribution and Classification (SACA) criteria for mTBI (without requirement of clinical neuropsychological impairment)
  • Chronic pain: pain that persists for \>6 months and is of moderate to severe intensity with a score of \>5 on specific items on the Brief Pain Inventory (BPI)
  • Fully vaccinated against COVID-19 prior to study participation

Exclusion

  • Contraindications to iTBS/TMS (e.g. epilepsy, history of anoxic brain injury or heart disease)
  • Contraindications to MRI (e.g., claustrophobia, ferromagnetic metal implants)
  • Pain believed to be associated with cardiac or ischemic conditions
  • Active seizure disorder, or if they are taking psychostimulants (e.g. amphetamines), anticholinergics or other medications that may increase their risk of having seizures
  • History of moderate to severe TBI
  • History of or current psychosis not due to an external cause (e.g., due to illicit drug use)
  • Are pregnant or nursing
  • Within 12 weeks of a major surgery/operation
  • Have questionably valid test profiles

Key Trial Info

Start Date :

June 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 31 2023

Estimated Enrollment :

19 Patients enrolled

Trial Details

Trial ID

NCT04517604

Start Date

June 1 2021

End Date

August 31 2023

Last Update

July 16 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Edward Hines Jr. VA Hospital, Hines, IL

Hines, Illinois, United States, 60141-3030